Penumbra Inc PEN

Latest FY: 2025 Healthcare Medical Devices
Market Price $327.06
Market Cap $12.85B
P/E Ratio 72.36
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑17.5% YoY
$1.40B
3-Yr CAGR: 18.3%
Net Income ↑1,168.1% YoY
$177.69M
Net Margin: 12.7%
Free Cash Flow ↑18.8% YoY
$174.93M
FCF Yield: 1.36%
EPS (Diluted) ↑1,155.6% YoY
$4.52
Basic: $4.57
Return on Equity Efficiency
12.4%
ROA: 353.3%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (PEN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $263.3M $170.8M $14.8M $0.44 $-12.8M $-26.4M
FY 2017 $333.8M +26.8% $217.1M $4.7M -68.6% $0.13 -70.5% $12.7M $0.2M +100.6%
FY 2018 $444.9M +33.3% $292.5M $6.6M +41.7% $0.18 +38.5% $28.8M $19.2M +11,978.6%
FY 2019 $547.4M +23.0% $372.0M $48.5M +634.1% $1.34 +644.4% $26.7M $4.5M -76.3%
FY 2020 $560.4M +2.4% $338.2M $-15.7M -132.4% $-0.44 -132.8% $-33.2M $-58.0M -1,376.6%
FY 2021 $747.6M +33.4% $475.4M $5.3M +133.7% $0.14 +131.8% $9.5M $-11.7M +79.9%
FY 2022 $847.1M +13.3% $535.2M $-2.0M -137.9% $-0.05 -135.7% $-55.7M $-75.0M -541.9%
FY 2023 $1,058.5M +25.0% $682.6M $91.0M +4,643.2% $2.32 +4,740.0% $97.3M $82.1M +209.6%
FY 2024 $1,194.6M +12.9% $755.0M $14.0M -84.6% $0.36 -84.5% $168.5M $147.3M +79.4%
FY 2025 $1,403.7M +17.5% $942.4M $177.7M +1,168.1% $4.52 +1,155.6% $238.7M $174.9M +18.8%
$

Valuation

Market Price $327.06
Market Cap $12.85B
Enterprise Value N/A
P/E Ratio 72.36
P/B Ratio 9.01
FCF Yield 1.36%
Dividend Yield N/A
Shares Outstanding 39,331,400
%

Profitability & Margins

Gross Margin 67.14%
Operating Margin 13.48%
Net Margin 12.66%
Return on Equity (ROE) 12.45%
Return on Assets (ROA) 353.27%
Asset Turnover 27.91x
Revenue 3-Yr CAGR 18.33%
🛡️

Financial Health & Liquidity

Current Ratio 0.38
Cash Ratio 1.41
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $186.90M
Total Debt N/A
Book Value / Share $36.30
💧

Cash Flow Efficiency

Operating Cash Flow $238.66M
Capital Expenditures (CapEx) $63.73M
Free Cash Flow $174.93M
OCF / Revenue 17.00%
FCF / Revenue 12.46%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $4.52
EPS (Basic) $4.57
Dividends / Share N/A
Book Value / Share $36.30
EPS YoY Growth 1,155.56%
🏛️

Balance Sheet (FY 2025)

Total Assets $50.30M
Total Liabilities $132.16M
Stockholders' Equity $1.43B
Current Assets $50.30M
Current Liabilities $132.16M